Indianapolis-based drugmaker Eli Lilly and Company has announced price ... Additionally, Lilly is launching Rezvoglar (insulin glargine-aglr) injection, a basal insulin that is biosimilar to ...

After years of preparation, Eli Lilly is on the brink of launching ... including Humalog and Lyumjev, both insulin lispro-based, and insulin glargine brand Basaglar. "Despite technological ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

A new pill is helping people with Type 2 diabetes lose weight and lower blood sugar in a phase-three clinical trial.

Eli Lilly announced the results of a clinical trial for its new pill, which the company said causes nearly 8% weight loss at certain dosages.

Notably, GLP-1 drugs help regulate blood sugar, insulin levels, and appetite, mainly treating type 2 diabetes and, more recently, obesity. Eli Lilly currently markets two GLP-1 receptor agonist ...

Drugmaker Eli Lilly said the first trial showed similar ... The hormones help regulate blood sugar by triggering the pancreas to release insulin, another hormone, and slowing the release of ...

(CNN) — Drugmaker Eli Lilly said Thursday that an experimental ... People who have diabetes can’t make enough insulin, a hormone the pancreas makes to help the body keep blood sugar levels ...